CLINICAL_TRIALS
research
· 2026-01-06
Clinical Trial Update: Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study [NA]
Summary
This multicenter, single-arm trial evaluates propranolol in combination with a novel endocrine therapy and androgen deprivation therapy as neoadjuvant treatment…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhongda Hospital | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING